aafq smgt-glp-1 New Eli Lilly trial suggests weight loss pill is as strong as Ozempic Indications for GLP-1/GIP RA Summary

Week 17 and beyond: maintenance At the 2.4 mg maintenance dose, weight loss continues steadily

Graphical Abstract 1 Introduction Neurological conditions, including central nervous system (CNS) disorders, have emerged as the leading cause of illness and disability worldwide, affecting more than 3 billion individuals more than one-third of the global population based on a study in 2021 (GBD, 2021 Nervous System Disorders Collaborators, 2024)

10.1097/WNR.0b013e32832fbf14 [DOI] [PubMed] [Google Scholar] Hamilton J

doi: 10.1007/s11901-016-0295-9, 17

If you dont know what youre taking, you should probably avoid it, Prof Tony Cass says

NICE guidance recommends at least 150 minutes of moderate-intensity aerobic activity per week, following a Mediterranean-style diet, reducing refined carbohydrates and added sugars, and limiting alcohol consumption in line with UK Chief Medical Officers' guidance